• 제목/요약/키워드: 21-hydroxylase deficiency

검색결과 11건 처리시간 0.034초

A case of 17 alpha-hydroxylase deficiency

  • Kim, Sung Mee;Rhee, Jeong Ho
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제42권2호
    • /
    • pp.72-76
    • /
    • 2015
  • $17{\alpha}$-hydroxylase and 17,20-lyase are enzymes encoded by the CYP17A1 gene and are required for the synthesis of sex steroids and cortisol. In $17{\alpha}$-hydroxylase deficiency, there are low blood levels of estrogens, androgens, and cortisol, and resultant compensatory increases in adrenocorticotrophic hormone that stimulate the production of 11-deoxycorticosterone and corticosterone. In turn, the excessive levels of mineralocorticoids lead to volume expansion and hypertension. Females with $17{\alpha}$-hydroxylase deficiency are characterized by primary amenorrhea and delayed puberty, with accompanying hypertension. Affected males usually have female external genitalia, a blind vagina, and intra-abdominal testes. The treatment of this disorder is centered on glucocorticoid and sex steroid replacement. In patients with $17{\alpha}$-hydroxylase deficiency who are being raised as females, estrogen should be supplemented, while genetically female patients with a uterus should also receive progesterone supplementation. Here, we report a case of a 21-year-old female with $17{\alpha}$-hydroxylase deficiency who had received inadequate treatment for a prolonged period of time. We also include a brief review of the recent literature on this disorder.

지속된 황달로 내원한 21-수산화효소 결핍증 남아 증례 (A Male Neonate with Prolonged Jaundice Secondary to 21-hydroxylase Deficiency)

  • 곽민욱;이예나;김구환;강민재
    • 대한유전성대사질환학회지
    • /
    • 제24권1호
    • /
    • pp.37-42
    • /
    • 2024
  • 선천성 부신 과형성증, 21-수산화효소 결핍증은 부신스테로이드 생성에 영향을 미치는 상염색체 열성 질환으로, 무기질코르티코이드와 글루코코르티코이드의 합성이 저하됩니다. 선천성 부신 과형성증은 저혈압, 무기력, 구토, 저혈당과 같은 증상을 유발할 수 있으며, 염분소실형에서 심각한 경우 생명을 위협하는 부신 위기를 초래할 수 있습니다. 이 보고는 전형적인 부신 위기 증상 없이 지속되는 황달로 내원하여 염분소실형의 복합 이형접합체로 진단받은 드문 사례를 제시합니다. 선천성 부신 과형성증의 신속한 진단과 치료가 심각한 합병증을 예방하는 데 필요함을 강조하며, 신생아 선별검사와 철저한 임상 관찰의 중요성을 강조하는 바 입니다.

  • PDF

Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care

  • Choi, Jin-Ho;Yoo, Han-Wook
    • Clinical and Experimental Pediatrics
    • /
    • 제60권2호
    • /
    • pp.31-37
    • /
    • 2017
  • Steroid 21-hydroxylase deficiency is the most prevalent form of congenital adrenal hyperplasia (CAH), accounting for approximately 95% of cases. With the advent of newborn screening and hormone replacement therapy, most children with CAH survive into adulthood. Adolescents and adults with CAH experience a number of complications, including short stature, obesity, infertility, tumor, osteoporosis, and reduced quality of life. Transition from pediatric to adult care and management of long-term complications are challenging for both patients and health-care providers. Psychosocial issues frequently affect adherence to glucocorticoid treatment. Therefore, the safe transition of adolescents to adult care requires regular follow-up of patients by a multidisciplinary team including pediatric and adult endocrinologists. The major goals for management of adults with 21-hydroxylase deficiency are to minimize the long-term complications of glucocorticoid therapy, reduce hyperandrogenism, prevent adrenal or testicular adrenal rest tumors, maintain fertility, and improve quality of life. Optimized medical or surgical treatment strategies should be developed through coordinated care, both during transition periods and throughout patients' lifetimes. This review will summarize current knowledge on the management of adults with CAH, and suggested appropriate approaches to the transition from pediatric to adult care.

선천성 부신 과형성증(21-hydroxylase 결핍)의 신생아 선별 검사 후 진단 알고리즘 (A Diagnostic Algorithm after Newborn Screening for 21-hydroxylase Deficiency)

  • 조성윤;고정민;이경아
    • 대한유전성대사질환학회지
    • /
    • 제16권2호
    • /
    • pp.70-78
    • /
    • 2016
  • 선천성 부신 과형성증 중 가장 흔한 21-hydroxy-lase deficiency (21-OHD)는 신생아 선별검사에서 17-hydroxyprogesterone (17-OHP)의 증가로 조기 진단이 가능하다. 17-OHP가 애매하게 증가되는 경우에는 ACTH 자극 검사가 필요하며, 이 검사는 nonclassical (NC형) 21-OHD 진단의 gold standard이다. 전형적인 임상 증상이 없는 경우, 예를 들어 남성화가 심하지 않은 여아, 경한 simple virilizing (SV)형 남아나 신생아 선별 검사에서 발견되지 않을 수 있는 NC형 환자의 경우, 분자유전학적 검사가 진단에 도움을 줄 수 있으며, 이는 예후 에측 및 유전 상담에도 도움이 된다. 미숙아와 저체중 출생아의 경우는 17-OHP가 위양성을 보이기 쉬우므로 출생 주수나 출생 체중에 따른 cutoff 값 설정이 필요하다. 높은 위양성률을 극복하기 위해 기존 RIA방법에 비해 최근 LC-MS/MS가 민감도와 특이도를 높이는 검사로 주목 받고 있다. 21-OHD 신생아 선별 검사의 효율성을 높이기 위해서는 SW형 남아를 조기에 발견하고, 여아에서 성별 결정을 조기에 올바르게 하고, NC형 환자를 찾아내고, 미숙아/저체중 출생아/아픈 신생아에서 위양성률을 낮추어서 불필요한 재검 및 경제적/심리적 부담을 최소화 하기 위한 노력이 필요하다. 무엇보다 21-OHD가 임상적으로 확실하게 의심되는 경우에는 확진 검사에 앞서 적절한 치료가 조기에 시작되어야 한다. 저자들은 본 종설에서 21-OHD의 신생아 선별 검사 후 진단 알고리즘에 대해 최신 문헌들에 근거하여 가이드라인을 제시하는 바이다.

  • PDF

선천 부신 과다형성 환자에서 발생한 고환 부신 잔류 종양 1례 (A case of testicular adrenal rest tumor in a male child with congenital adrenal hyperplasia)

  • 김주화;윤경아;신충호;양세원
    • Clinical and Experimental Pediatrics
    • /
    • 제51권9호
    • /
    • pp.1018-1022
    • /
    • 2008
  • 선천 부신 과다형성 환자에서 고환 부신 잔류 종양은 흔하게 발생한다. 대개 이 종양은 적절한 corticosteroid 억제 치료로 호전될 수 있다. 저자들은 양측성 고환 부신 잔류 종양을 보인 21-hydroxylase 결핍증 환아에게서 corticosteroid를 투여하였으나 반응하지 않아 고환 적출술을 시행한 사례를 경험하였기에 보고하는 바이다.

Duplication and deletion of 21 hydroxylase gene among the normal Korean subjects and in adrenogenital syndrome patients

  • Jin, Dong-Kyu;Beck, Nam-Seon;Oh, Phil-Soo;Whang, Hye-Zin;Koh, Si-Whan;Kim, Jung-Sim;Oh, Myung-Ryurl
    • Journal of Genetic Medicine
    • /
    • 제1권1호
    • /
    • pp.27-31
    • /
    • 1997
  • Steroid 21 hydroxylase deficiency is a major cause of congenital adrenal hyperplasia (CAH) and is caused by genetic impairment of the gene (CYP21B). In the human genome, CYP21B is located within the MHC class III region on the short arm of chromosome 6. Most of the genes in this region are highly polymorphic and crowded. Also the CYP21B gene is accompanied by its pseudogene (CYP21A) and tandemly arranged with two genes of fourth component of complement. This highly complex gene cluster in this area may predispose genetic instability of CYP21, i.e. mutations. In this study, tried to investigate the frequency of duplication and deletion of CYP21 and patterns of the genetic alterations of these genes.We also compared the genetic alteration in normal subjects with those of the CAH patients. The results showed that 15% of the normal korean population have duplication or deletion of CYP21. There was one normal subject with heterozygous deletion of CYP21B. Of the 5 CAH patients examined, 2 were found to show abnormal patterns. One was a large-scale gene conversion and the other a gene conversion associated with deletion involving both CYP21B and C4 locus II gene. Through this study, we carne to the conclusion that the duplication or even deletion of CYP21 and C4 might be quite a common event in the Korean population and these rearrangements must be regarded as polymorphisms. It could contribute to a high incidencs of CAH by providing a genetic pool of instable CYP21.

  • PDF

Purity assignment of 17α-hydroxyprogesterone by mass balance method to establish traceability in measurement

  • Lee, Hwa Shim;Park, Su Jin
    • 분석과학
    • /
    • 제32권6호
    • /
    • pp.225-232
    • /
    • 2019
  • Traceability establishment in chemical measurements is a like a linkage established through an unbroken chain from the measured results to the international system (SI) of units. The primary process for traceability establishment is the purity assignment of a target material to be measured. In this study, we studied the purity assignment of 17α-hydroxyprogesterone (17-OHP). The presence of 17-OHP is indicative of congenital adrenal hyperplasia (CAH) and it builds up due to the deficiency of 21-hydroxylase and 11β-hydroxylase enzyme in the human blood. The purity assignment of 17-OHP was performed by the mass balance method, in which the impurities are categorized into four classes: total related structural impurities, water, residual organic solvents, and nonvolatiles/inorganics. The total related structural impurities were characterized by HPLC-UV; water content was determined by Karl-Fisher coulometer; and the total residual solvents and nonvolatiles/inorganics were determined by TGA. The purity of 17-OHP from a commercial manufacturer was calculated as 993.30 mg/g, and the expanded uncertainty was 0.58 mg/g. The proposed method was validated by uncertainty evaluation and comparing with the actual value of purity.

A sclerosing stromal tumor of the ovary with masculinization in a premenarchal girl

  • Park, Soo-Min;Kim, Young-Nam;Woo, Young-Jong;Choi, Ho-Sun;Lee, Ji-Shin;Heo, Suk-Hee;Kim, Chan-Jong
    • Clinical and Experimental Pediatrics
    • /
    • 제54권5호
    • /
    • pp.224-227
    • /
    • 2011
  • A sclerosing stromal tumor of the ovary is an extremely rare benign tumor; it usually is found during the second and third decades of life. Patients present with pelvic pain or a palpable abdominal mass. Hormonal effects such as masculinization are uncommon. Here, an 11-year old premenarchal girl presented with deepening of the voice. In addition, clitoromegaly and hirsutism with a male suprapubic hair pattern were observed. The laboratory findings showed that the testosterone level was elevated to 3.67 ng/ml, andostenedione to above 10 ng/ml, dehydroepiandrosterone-sulfate to 346 ${\mu}g$/dl and 17-hydroxy progesterone (17-OHP) to 11.28 ng/ml. The chromosome evaluation revealed a 46,XX female karyotype. An adrenocorticotropic hormone stimulation test was performed. The 17-OHP to cortisol ratio in 30 minutes was 0.045, which suggested a heterozygote for the 21-hydroxylase deficiency. However, the CYP21A2 gene encoding steroid 21-hydroxylase showed normal. The pelvic ultrasound showed a heterogeneous mass consisting of predominantly solid tissue in the pelvic cavity. The pelvic magnetic resonance imaging revealed an $8.9{\times}6.2{\times}6.6$ cm mass of the left ovary. A left oophrectomy was performed and microscopic examination confirmed a sclerosing stromal tumor. Immunohistochemical studies showed that the tumor was positive for smooth muscle actin and vimentin, but negative for S-100 protein and cytokeratin. Following surgery, the hormone levels returned to the normal range and the hirsutism resolved.

장기간 치료받은 부신 피질 과형성증 환아에서 발생한 부신 피질 종양 1례 (A case of adrenocortical adenoma following long-term treatment in a patient with congenital adrenal hyperplasia)

  • 노승림;박소현;정민호;이병철
    • Clinical and Experimental Pediatrics
    • /
    • 제50권3호
    • /
    • pp.302-305
    • /
    • 2007
  • 최근 해상도가 항진된 방사선학적 검사가 널리 사용되면서, 21-수산화효소 결핍증에 의한 선천성 부신 피질 과형성증 환아에서 부신피질종양이 발견되는 경우가 많아지고 있다. 일반적으로 적절한 스테로이드 호르몬 치료를 받은 21-수산화효소 결핍증 소아에서 부신피질 종양의 발생률는 매우 드물다. 저자들은 생후 초기부터 적절한 용량의 스테로이드 치료로 잘 조절되고 있는 염분소실형 21-수산화효소 결핍증을 가진 12세 여아에서 부신 종양이 우연히 발견된 1례를 보고하고자 한다.

Testicular adrenal rest tumors in a patient with untreated congenital adrenal hyperplasia

  • Jin, Hye-Young;Choi, Jin-Ho;Kim, Gu-Hwan;Lee, Chung-Sik;Yoo, Han-Wook
    • Clinical and Experimental Pediatrics
    • /
    • 제54권3호
    • /
    • pp.137-140
    • /
    • 2011
  • Testicular adrenal rest tumors (TARTs) are considered to be formed from aberrant adrenal tissue that has become hyperplastic because of elevated adrenocorticotropic hormone (ACTH) in male patients with congenital adrenal hyperplasia (CAH). A 6-year-old boy presented with testicular enlargement and pubic hair. He was diagnosed with CAH complicated by precocious puberty. However, he was not followed-up. At the age of 17, he visited the outpatient clinic because of testicular enlargement and short stature. His right and left testicles were $10{\times}6$ cm and $7.5{\times}4.5$ cm, respectively. His height was 155.1 cm (standard deviation score (SDS), -2.90). The diagnosis of CAH due to 21 hydroxylase deficiency was confirmed by mutation analysis of CYP21A2. Histological examination of the testes showed large, polygonal, eosinophilic cells with round nuclei and prominent nucleoli, which were suggestive of TARTs. He was treated with dexamethasone for 3 weeks and tumors regressed. Subsequently, dexamethasone was replaced by prednisolone and $9{\alpha}$-fludrocortisone; thereafter, the reduced testis size has been maintained.